Nanosonics Limited (NNCSF)
USD 3.0
(-6.54%)
USD 3.0
(-6.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -120.24 Million AUD | -18.54% |
| 2023 | -101.43 Million AUD | -22.51% |
| 2022 | -82.8 Million AUD | 11.48% |
| 2021 | -93.53 Million AUD | -4.89% |
| 2020 | -89.17 Million AUD | -24.44% |
| 2019 | -71.65 Million AUD | -4.63% |
| 2018 | -68.48 Million AUD | -11.11% |
| 2017 | -61.63 Million AUD | -30.88% |
| 2016 | -47.09 Million AUD | -27.22% |
| 2015 | -37.02 Million AUD | -182.21% |
| 2014 | -13.11 Million AUD | 20.49% |
| 2013 | -16.49 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -107.66 Million AUD | 2.73% |
| 2024 FY | -120.24 Million AUD | -18.54% |
| 2024 Q4 | -120.24 Million AUD | 7.18% |
| 2024 Q3 | -129.55 Million AUD | -20.33% |
| 2024 Q1 | -110.68 Million AUD | -9.11% |
| 2023 Q2 | -87.83 Million AUD | 2.96% |
| 2023 FY | -101.43 Million AUD | -22.51% |
| 2023 Q4 | -101.43 Million AUD | 2.76% |
| 2023 Q1 | -90.51 Million AUD | -9.32% |
| 2023 Q3 | -104.32 Million AUD | -18.77% |
| 2022 FY | -82.8 Million AUD | 11.48% |
| 2022 Q3 | -85.35 Million AUD | 1.13% |
| 2022 Q4 | -82.8 Million AUD | 2.99% |
| 2022 Q2 | -86.32 Million AUD | 2.23% |
| 2022 Q1 | -88.29 Million AUD | 5.6% |
| 2021 Q4 | -93.53 Million AUD | 1.56% |
| 2021 Q2 | -85.82 Million AUD | 0.91% |
| 2021 Q1 | -86.61 Million AUD | 2.87% |
| 2021 FY | -93.53 Million AUD | -4.89% |
| 2021 Q3 | -95.01 Million AUD | -10.71% |
| 2020 Q1 | -81.08 Million AUD | -12.46% |
| 2020 Q3 | -90.4 Million AUD | -13.54% |
| 2020 Q4 | -89.17 Million AUD | 1.37% |
| 2020 FY | -89.17 Million AUD | -24.44% |
| 2020 Q2 | -79.62 Million AUD | 1.81% |
| 2019 Q3 | -72.1 Million AUD | -1.62% |
| 2019 Q4 | -72.1 Million AUD | 0.0% |
| 2019 FY | -71.65 Million AUD | -4.63% |
| 2019 Q1 | -70.95 Million AUD | -2.96% |
| 2019 Q2 | -70.95 Million AUD | 0.0% |
| 2018 Q2 | -65.77 Million AUD | 0.0% |
| 2018 Q4 | -68.91 Million AUD | 0.0% |
| 2018 FY | -68.48 Million AUD | -11.11% |
| 2018 Q3 | -68.91 Million AUD | -4.77% |
| 2018 Q1 | -65.77 Million AUD | -6.01% |
| 2017 Q4 | -62.04 Million AUD | 0.0% |
| 2017 Q2 | -55.72 Million AUD | 0.0% |
| 2017 Q1 | -55.72 Million AUD | -17.33% |
| 2017 FY | -61.63 Million AUD | -30.88% |
| 2017 Q3 | -62.04 Million AUD | -11.34% |
| 2016 FY | -47.09 Million AUD | -27.22% |
| 2016 Q3 | -47.49 Million AUD | -48.01% |
| 2016 Q2 | -32.08 Million AUD | 0.0% |
| 2016 Q4 | -47.49 Million AUD | 0.0% |
| 2016 Q1 | -32.08 Million AUD | 13.32% |
| 2015 Q3 | -37.02 Million AUD | -141.25% |
| 2015 Q1 | -15.34 Million AUD | -16.98% |
| 2015 Q4 | -37.02 Million AUD | 0.0% |
| 2015 FY | -37.02 Million AUD | -182.21% |
| 2015 Q2 | -15.34 Million AUD | 0.0% |
| 2014 Q2 | -13.81 Million AUD | 0.0% |
| 2014 Q4 | -13.11 Million AUD | 0.0% |
| 2014 FY | -13.11 Million AUD | 20.49% |
| 2014 Q1 | -13.81 Million AUD | 16.29% |
| 2014 Q3 | -13.11 Million AUD | 5.02% |
| 2013 Q3 | -16.49 Million AUD | 35.96% |
| 2013 FY | -16.49 Million AUD | 0.0% |
| 2013 Q2 | -25.76 Million AUD | 0.0% |
| 2013 Q4 | -16.49 Million AUD | 0.0% |
| 2013 Q1 | -25.76 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 25171.148% |
| Ansell Limited | -54.99 Million USD | -118.647% |
| Ansell Limited | -55.1 Million USD | -118.238% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | -229.511% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -114311.713% |
| Psykey, Inc. | 634.59 Thousand USD | 19048.995% |
| ConvaTec Group Plc | 1.2 Billion USD | 110.016% |
| ConvaTec Group Plc | 1.2 Billion USD | 110.002% |
| Encision Inc. | 1.29 Million USD | 9416.623% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 5308.477% |
| Innovative MedTech Inc. | 1.76 Million USD | 6913.994% |
| LifePoint, Inc. | -3.26 Million USD | -3584.076% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 2551.969% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 5661.933% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -277585.662% |
| Reflect Scientific, Inc. | -1.03 Million USD | -11514.816% |
| SmileDirectClub, Inc. | 778.67 Million USD | 115.443% |
| Sector 10, Inc. | 163 Thousand USD | 73872.392% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 71.202% |
| SheerVision, Inc. | 57.34 Thousand USD | 209779.33% |
| United Health Products, Inc. | 660.56 Thousand USD | 18303.851% |
| Vasamed, Inc. | 22.12 Thousand USD | 543672.005% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 4670.087% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 15670.668% |